Association of Angiotensin II Type 1 Receptor (AT1R) Gene Polymorphism with Angiotensin II Serum Levels in Patients

M Prasad1, D Rajarajeswari1, K Ramlingam1

  • 1Department of Biochemistry, Narayana Medical College and Hospital, Chinthareddy Palem, Nellore, Andhra Pradesh 524003 India.

Insights

Essential hypertension (EH) risk is linked to the AT1R gene

Area of Science:

  • Cardiovascular Genetics
  • Molecular Medicine
  • Hypertension Research

Background:

  • Essential hypertension (EH) is a complex, polygenic condition with significant morbidity and mortality.
  • EH contributes to severe comorbidities like stroke, myocardial infarction, cardiac, and renal failure.
  • There is a need for population-based studies to understand EH pathophysiology and improve diagnosis and treatment.

Purpose of the Study:

  • To investigate the genotype and allele frequencies of the AT1R gene A1166C polymorphism in Indian patients with EH.
  • To correlate these genetic variations with serum Angiotensin II levels in hypertensive individuals.
  • To assess the association between AT1R gene polymorphism and the risk of developing essential hypertension in the Indian population.

Main Methods:

  • A case-control study involving 200 Indian patients with EH and 200 age- and gender-matched controls.
  • Genotyping of the AT1R gene A1166C polymorphism was performed.
  • Serum Angiotensin II levels were measured and correlated with genotypes.

Main Results:

  • The C/A heterozygote and allele C of the AT1R gene A1166C polymorphism were significantly associated with an increased risk of EH in both men and women.
  • Patients with EH exhibited higher serum Angiotensin II levels, particularly those with C/A and AA genotypes.
  • A significant association was found between the 1166 C/A polymorphism of the AT1R gene and an elevated risk of hypertension in the Indian population.

Conclusions:

  • The 1166 C/A polymorphism in the AT1R gene is a significant genetic risk factor for essential hypertension in the Indian population.
  • This polymorphism is associated with elevated serum Angiotensin II levels, suggesting a mechanistic link to hypertension.
  • These findings contribute to understanding the genetic underpinnings of EH and may inform future diagnostic or therapeutic strategies.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
799
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
743
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
31
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
729